Research progress on mental intervention in patients with diabetic retinopathy

FENG Yalin; ZHOU Yuanting; ZOU Wenjun

doi:10.7619/jcmp.20242834

Journal of Clinical Medicine in Practice > 2025 > 29(4): 134-138, 148. > DOI: 10.7619/jcmp.20242834

FENG Yalin, ZHOU Yuanting, ZOU Wenjun. Research progress on mental intervention in patients with diabetic retinopathy[J]. Journal of Clinical Medicine in Practice, 2025, 29(4): 134-138, 148. DOI: 10.7619/jcmp.20242834

Citation:

PDF (968 KB)

Research progress on mental intervention in patients with diabetic retinopathy

1.
Department of Ophthalmology, Central Hospital Affiliated to Jiangnan University, Wuxi Second People's Hospital, Wuxi, Jiangsu, 214002
2.
Department of Surgery, Central Hospital Affiliated to Jiangnan University, Wuxi Second People's Hospital, Wuxi, Jiangsu, 214002

More Information

Received Date: July 03, 2024
Revised Date: September 01, 2024

Graphical Abstract

Abstract

Abstract

Diabetic retinopathy is one of the most common and specific chronic complications of diabetes mellitus, which is a serious and irreversible progressive blinding eye disease. The visual impairment caused by the progression of the disease and the economic burden caused by the treatment of the disease lead to psychological problems such as anxiety and depression, affecting the quality of life and physical and mental health, and increasing the burden on the family and society. This article reviewed the current status of epidemiological research on DR, discussed the correlation of DR with anxiety and depression and its influencing factors, analyzed the research progress of evaluation and intervention methods, aiming to provide assistance for improving patients' treatment compliance and quality of life.
- diabetic retinopathy,
- blood sugar control,
- negative emotions,
- anxiety,
- depression

FullText(HTML)

References (52)

References

[1]	SAEEDI P, PETERSOHN I, SALPEA P, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the international diabetes federation diabetes atlas, 9^th edition[J]. Diabetes Res Clin Pract, 2019, 157: 107843. doi: 10.1016/j.diabres.2019.107843
[2]	ZHANG B, WANG Q, ZHANG X C, et al. Association between self-care agency and depression and anxiety in patients with diabetic retinopathy[J]. BMC Ophthalmol, 2021, 21(1): 123. doi: 10.1186/s12886-021-01883-w
[3]	LYU Z, CHEN Y L, ZHU Z T, et al. Associations of concomitant retinopathy and depression with mortality in a nationally representative population[J]. J Affect Disord, 2023, 336: 15-24. doi: 10.1016/j.jad.2023.05.040
[4]	BLOOM J M, MASON J O 3rd, MASON L, et al. Fears, depression, and anxieties of patients with diabetic retinopathy and implications for education and treatment[J]. J Vitreoretin Dis, 2020, 4(6): 484-489. doi: 10.1177/2474126420936118
[5]	SUN H, SAEEDI P, KARURANGA S, et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045[J]. Diabetes Res Clin Pract, 2022, 183: 109119. doi: 10.1016/j.diabres.2021.109119
[6]	YAU J W, ROGERS S L, KAWASAKI R, et al. Global prevalence and major risk factors of diabetic retinopathy[J]. Diabetes Care, 2012, 35(3): 556-564. doi: 10.2337/dc11-1909
[7]	TEO Z L, THAM Y C, YU M, et al. Global prevalence of diabetic retinopathy and projection of burden through 2045: systematic review and meta-analysis[J]. Ophthalmology, 2021, 128(11): 1580-1591. doi: 10.1016/j.ophtha.2021.04.027
[8]	邓宇轩, 叶雯青, 孙艳婷, 等. 中国糖尿病视网膜病变患病率的荟萃分析[J]. 中华医学杂志, 2020, 100(48): 3846-3852. doi: 10.3760/cma.j.cn112137-20200925-02720
[9]	KHOO K, MAN R E K, REES G, et al. The relationship between diabetic retinopathy and psychosocial functioning: a systematic review[J]. Qual Life Res, 2019, 28(8): 2017-2039. doi: 10.1007/s11136-019-02165-1
[10]	REES G, XIE J, FENWICK E K, et al. Association between diabetes-related eye complications and symptoms of anxiety and depression[J]. JAMA Ophthalmol, 2016, 134(9): 1007-1014. doi: 10.1001/jamaophthalmol.2016.2213
[11]	MORJARIA R, ALEXANDER I, PURBRICK R M J, et al. Impact of diabetic retinopathy on sleep, mood, and quality of life[J]. Invest Ophthalmol Vis Sci, 2019, 60(6): 2304-2310. doi: 10.1167/iovs.18-26108
[12]	孙小佳, 窦国睿. 糖尿病视网膜病变患者焦虑和抑郁状态的研究进展[J]. 中华医学杂志, 2022, 102(47): 3796-3800. doi: 10.3760/cma.j.cn112137-20220708-01507
[13]	NOUWEN A, ADRIAANSE M C, VAN DAM K, et al. Longitudinal associations between depression and diabetes complications: a systematic review and meta-analysis[J]. Diabet Med, 2019, 36(12): 1562-1572. doi: 10.1111/dme.14054
[14]	HUANG Y Q, WANG Y, WANG H, et al. Prevalence of mental disorders in China: a cross-sectional epidemiological study[J]. Lancet Psychiatry, 2019, 6(3): 211-224. doi: 10.1016/S2215-0366(18)30511-X
[15]	XU L, CHEN S Q, XU K, et al. Prevalence and associated factors of depression and anxiety among Chinese diabetic retinopathy patients: a cross-sectional study[J]. PLoS One, 2022, 17(4): e0267848. doi: 10.1371/journal.pone.0267848
[16]	SIEU N, KATON W, LIN E H B, et al. Depression and incident diabetic retinopathy: a prospective cohort study[J]. Gen Hosp Psychiatry, 2011, 33(5): 429-435. doi: 10.1016/j.genhosppsych.2011.05.021
[17]	廖坤锋, 杨西宁, 刘环, 等. 糖尿病共病抑郁症的发病机制及影响因素的研究进展[J]. 循证护理, 2023, 9(2): 260-263.
[18]	LIU X, LAI S K, MA S S, et al. Development of a novel retina-based diagnostic score for early detection of major depressive disorder: an interdisciplinary view[J]. Front Psychiatry, 2022, 13: 897759. doi: 10.3389/fpsyt.2022.897759
[19]	中华医学会, 中华医学会杂志社, 中华医学会全科医学分会, 等. 抑郁症基层诊疗指南(2021年)[J]. 中华全科医师杂志, 2021, 20(12): 1249-1260. doi: 10.3760/cma.j.cn114798-20211020-00778
[20]	中华医学会, 中华医学会杂志社, 中华医学会全科医学分会, 等. 广泛性焦虑障碍基层诊疗指南(2021年)[J]. 中华全科医师杂志, 2021, 20(12): 1232-1241. doi: 10.3760/cma.j.cn114798-20211025-00790
[21]	FLAXEL C J, ADELMAN R A, BAILEY S T, et al. Diabetic retinopathy preferred practice pattern[J]. Ophthalmology, 2020, 127(1): 66-145. doi: 10.1016/j.ophtha.2019.09.025
[22]	郭文梅, 罗羽, 卞薇, 等. 老年糖尿病视网膜病变病人报告结局研究进展[J]. 护理研究, 2022, 36(16): 2954-2957. doi: 10.12102/j.issn.1009-6493.2022.16.024
[23]	MARTIN J, STREIT F, TREUTLEIN J, et al. Expert and self-assessment of lifetime symptoms and diagnosis of major depressive disorder in large-scale genetic studies in the general population: comparison of a clinical interview and a self-administered checklist[J]. Psychiatr Genet, 2017, 27(5): 187-196. doi: 10.1097/YPG.0000000000000182
[24]	俞华, 刘寰忠, 刘强, 等. 有无视网膜病变的糖尿病患者焦虑、抑郁状态及影响因素分析[J]. 中国科学技术大学学报, 2020, 50(3): 382-388. doi: 10.3969/j.issn.0253-2778.2020.03.017
[25]	马艳玲, 李燕飞, 刘艺, 等. 糖尿病视网膜病变患者焦虑抑郁现状及干预措施[J]. 国际护理学杂志, 2023, 42(2): 227-231. doi: 10.3760/cma.j.cn221370-20200401-00055
[26]	孙娟, 何红. 糖尿病视网膜病变危险因素的研究进展[J]. 中华眼底病杂志, 2020, 36(12): 986-990. doi: 10.3760/cma.j.cn511434-20191009-00317
[27]	ALTEMUS M, SARVAIYA N, NEILL EPPERSON C. Sex differences in anxiety and depression clinical perspectives[J]. Front Neuroendocrinol, 2014, 35(3): 320-330. doi: 10.1016/j.yfrne.2014.05.004
[28]	ZOU Y W, YOU W J, WANG J, et al. Depression and retinopathy in patients with type 2 diabetes mellitus: a meta-analysis[J]. Psychosom Med, 2021, 83(3): 239-246. doi: 10.1097/PSY.0000000000000924
[29]	ZHOU X H, BI B, ZHENG L Q, et al. The prevalence and risk factors for depression symptoms in a rural Chinese sample population[J]. PLoS One, 2014, 9(6): e99692. doi: 10.1371/journal.pone.0099692
[30]	LOW J R, GAN A T L, FENWICK E K, et al. Role of socio-economic factors in visual impairment and progression of diabetic retinopathy[J]. Br J Ophthalmol, 2021, 105(3): 420-425. doi: 10.1136/bjophthalmol-2020-316430
[31]	NAGDA D, MITCHELL W, ZEBARDAST N. The functional burden of diabetic retinopathy in the United States[J]. Albrecht Von Graefes Arch Fur Klin Und Exp Ophthalmol, 2021, 259(10): 2977-2986. doi: 10.1007/s00417-021-05210-3
[32]	张楠楠, 张珂, 倪晓丽, 等. 糖尿病视网膜病变患者治疗前疾病不确定感、心理弹性及自我感受负担的关系[J]. 中国健康心理学杂志, 2020, 28(9): 1330-1333.
[33]	HERNÁNDEZ-MORENO L, SENRA H, MORENO N, et al. Is perceived social support more important than visual acuity for clinical depression and anxiety in patients with age-related macular degeneration and diabetic retinopathy[J]. Clin Rehabil, 2021, 35(9): 1341-1347. doi: 10.1177/0269215521997991
[34]	赵恩贤, 秦继跃, 许成国. 增殖性糖尿病性视网膜病变患者心理状态与社会支持的相关性[J]. 中国健康心理学杂志, 2019, 27(12): 1786-1789.
[35]	HIRAI F E, TIELSCH J M, KLEIN B E, et al. Ten-year change in vision-related quality of life in type 1 diabetes: Wisconsin epidemiologic study of diabetic retinopathy[J]. Ophthalmology, 2011, 118(2): 353-358. doi: 10.1016/j.ophtha.2010.06.022
[36]	XU X J, ZHAO X Y, QIAN D, et al. Investigating factors associated with depression of type 2 diabetic retinopathy patients in China[J]. PLoS One, 2015, 10(7): e0132616. doi: 10.1371/journal.pone.0132616
[37]	EKEMIRI K K, BOTCHWAY E N, EZINNE N E, et al. Comparative analysis of health- and vision-related quality of life measures among trinidadians with low vision and normal vision-a cross-sectional matched sample study[J]. Int J Environ Res Public Health, 2023, 20(14): 6436. doi: 10.3390/ijerph20146436
[38]	FRANK C R, XIANG X L, STAGG B C, et al. Longitudinal associations of self-reported vision impairment with symptoms of anxiety and depression among older adults in the United States[J]. JAMA Ophthalmol, 2019, 137(7): 793-800. doi: 10.1001/jamaophthalmol.2019.1085
[39]	胡可可, 惠延年, 杜红俊. 抗VEGF时代激光光凝治疗糖尿病视网膜病变的应用进展[J]. 国际眼科杂志, 2023, 23(8): 1285-1289.
[40]	盛群芳, 殷雪, 李弢. 强化心理应激对增殖性糖尿病视网膜病变患者术后应激的影响[J]. 中国健康心理学杂志, 2022, 30(10): 1505-1510.
[41]	KESSING L V, RYTGAARD H C, EKSTRØM C T, et al. Antidiabetes agents and incident depression: a nationwide population-based study[J]. Diabetes Care, 2020, 43(12): 3050-3060. doi: 10.2337/dc20-1561
[42]	SOLIMAN E, ESSMAT N, MAHMOUD M F, et al. Impact of some oral hypoglycemic agents on type 2 diabetes-associated depression and reserpine-induced depression in rats: the role of brain oxidative stress and inflammation[J]. Naunyn Schmiedebergs Arch Pharmacol, 2020, 393(8): 1391-1404. doi: 10.1007/s00210-020-01838-wg\|\|49\|7\|3692\|2023\|\|\|
[43]	中华医学会糖尿病学分会视网膜病变学组. 糖尿病相关眼病防治多学科中国专家共识(2021年版)[J]. 中华糖尿病杂志, 2021, 13(11): 1026-1042. doi: 10.3760/cma.j.cn115791-20211006-00534
[44]	中华医学会眼科学分会眼底病学组, 中国医师协会眼科医师分会眼底病学组. 我国糖尿病视网膜病变临床诊疗指南(2022年)[J]. 中华眼底病杂志, 2023, 39(2): 99-124. doi: 10.3760/cma.j.cn511434-20230110-00018
[45]	中国研究型医院学会糖尿病学专业委员会. 社区医疗机构糖尿病视网膜病变筛查工作流程与管理规范的专家共识(2023版)[J]. 中华糖尿病杂志, 2024, 16(1): 20-27. doi: 10.3760/cma.j.cn115791-20231010-00229
[46]	杜蓉冰, 吕素珍, 潘红英. 多学科团队协同延续护理在糖尿病视网膜病变患者中的应用[J]. 护理学杂志, 2020, 35(13): 86-89.
[47]	APOLINÁRIO-HAGEN J, DRVGE M, FRITSCHE L. Cognitive behavioral therapy, mindfulness-based cognitive therapy and acceptance commitment therapy for anxiety disorders: integrating traditional with digital treatment approaches[J]. Adv Exp Med Biol, 2020, 1191: 291-329. http://pubmed.ncbi.nlm.nih.gov/32002935/
[48]	周丹. 正念认知疗法在糖尿病患者相关痛苦中的应用研究[D]. 荆州: 长江大学, 2020.
[49]	王艳. 糖尿病视网膜病变病人围术期强化心理干预对负性情绪和生存质量的影响[J]. 护理研究, 2019, 33(4): 727-728.
[50]	张梦月, 施颖辉, 章晓贤, 等. 基于时机理论的糖尿病视网膜病变手术患者护理干预方案的构建[J]. 中华护理杂志, 2023, 58(24): 2957-2963. doi: 10.3761/j.issn.0254-1769.2023.24.002
[51]	谷乔, 李敏, 徐芳, 等. 综合心理护理模式对糖尿病视网膜病变手术患者的干预效果[J]. 中国医科大学学报, 2021, 50(2): 184-186.
[52]	YEKTA Z, XIE D W, BOGNER H R, et al. The association of antidepressant medications and diabetic retinopathy among people with diabetes[J]. J Diabetes Complications, 2015, 29(8): 1077-1084. doi: 10.1016/j.jdiacomp.2015.06.009

Cited By

Get Citation

PDF

XML

Article views (35) PDF downloads (5)

Turn off MathJax

Article Contents

Abstract

References

Research progress on mental intervention in patients with diabetic retinopathy

Abstract

References

Catalog

Export File

Citation

Format

Content